http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Myriad myRisk® Hereditary Cancer Test Demonstrates the Magnitude of Breast and Ovarian Cancer Risk in Nearly 100,000 Patients
-
Myriad Will Present Three New Hereditary Cancer Studies at the ASCO Annual Meeting
-
Myriad to Present New Research at the 2016 ASCO Annual Meeting
-
Myriad to Present Three New Studies at the AUA Annual Meeting
-
Myriad Genetics Announces Presentations at the 2016 American Association for Cancer Research Annual Meeting
-
Myriad myRisk® Hereditary Cancer Article in Journal of Clinical Oncology Highlights Importance of Expanding Genetic Testing for Breast Cancer Patients
-
The Myriad myRisk® Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer
-
Myriad Genetics (MYGN) Announces Presentation of Additional myPath Melanoma Test Data
-
Myriad Presents Second Pivotal Validation Study for Its myPath® Melanoma Test
-
Myriad Advances Proprietary myVision® Variant Classification Tools to a Broader Range of Cancer Risk Genes
-
Myriad Advances Prostate and Renal Cancer Molecular Diagnostic Tests at the 2016 ASCO Genitourinary Cancers Symposium
-
myChoice HRD(TM) Test Identifies Breast Cancer Patients Likely to Respond to Platinum-Containing Therapies
-
myChoice HRD(TM) Test Identifies Breast Cancer Patients Likely to Respond to Platinum-Containing Therapies
-
Myriad Genetics (MYGN) to Highlight myRisk Hereditary Cancer Test at 2015 SABCS
-
Multiple Scientific Presentations at the San Antonio Breast Cancer Symposium Highlight the Clinical Utility of the Myriad myRisk(TM) Hereditary Cancer Gene Panel Test
-
Multiple Scientific Presentations at the San Antonio Breast Cancer Symposium Highlight the Clinical Utility of the Myriad myRisk(TM) Hereditary Cancer Gene Panel Test
-
Myriad Will Present Eight Studies at the 2015 San Antonio Breast Cancer Symposium
-
Myriad Will Present Eight Studies at the 2015 San Antonio Breast Cancer Symposium
-
Myriad Genetics, Inc. (Nasdaq: MYGN) to Ring The Nasdaq Stock Market Opening Bell
-
Myriad Genetics, Inc. (Nasdaq: MYGN) to Ring The Nasdaq Stock Market Opening Bell
-
Tiger Global Shows New Stake in Etsy (ETSY), Fitbit (Fit), Raises NetFlix (NFLX), Lowers Alibaba (BABA) (more...)
-
Chris4Life and Myriad Launch "What's Your History" Week and FamilyHistoryTool(TM)
-
Chris4Life and Myriad Launch "What's Your History" Week and FamilyHistoryTool(TM)
-
Coleman's Tiger Global Management 13F Shows New Stakes in Kate (KATE), Vasco (VDSI), Increased Stake in Fleetcor Tech (FLT) ...
-
Tiger Global Management Shows News Stakes in Alibaba (BABA), GameStop (GME), JD.com (JD); Raises GoPro (GPRO); Liquidates Zynga (ZNGA)
-
Coleman's Tiger Global Takes New GoPro (GPRO), Mobileye (MBLY) Stakes; Exits Comcast (CMCSA), Netflix (NFLX) - 13F
-
Coleman's Tiger Global Management 13F Shows Netflix (NFLX), King Digital (KING) Entry; 3D Systems (DDD), Hertz (HTZ) Increase (MORE...)
-
Griffin's Blue Ridge Capital 13F Shows New MasterCard (MA), Visa (V) Stakes (more...)
-
Coleman's Tiger Global Management Shows news Stakes in Avis (CAR), UTI Worldwide (UTIW), Himax (HIMX); Liquidates Amazon (AMZN) (more...)
-
Griffin's Blue Ridge Capital Shows New Stakes in Allegion (ALLE), Castlight Health (CSLT), Myriad Genetics (MYGN), Walgreen (WAG) (more...)
-
Tiger Global Management Enters Gap (GPS), Restoration Hardware (RH), Twitter (TWTR) (more...)
-
Pre-Open Stock Movers 12/30: (BIOL) (KNDI) (CROX) Higher; (CANF) (MYGN) (TWTR) Lower (more...)

